Drug intelligence / Profile preview

HCW9201 + HCW9206

Development stage
Unknown
Lead developer
HCW Biologics
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous
01

Overview

HCW9201 + HCW9206 is a combination of two multifunctional fusion protein complexes used in a "Prime and Expand" strategy for adoptive cellular therapy with memory-like natural killer (NK) cells. HCW9201 is a fusion protein containing IL-12, IL-15, and IL-18 domains, used for priming NK cells to induce memory-like differentiation. HCW9206 is a fusion protein containing IL-7, IL-15, and IL-21 domains, used for expanding the primed NK cells in combination with an IgG1 antibody (HCW9101) that engages CD16 on NK cells. This approach results in significant expansion of memory-like NK cells, enhanced metabolic capacity, stable epigenetic remodeling, and improved antitumor activity and persistence in vivo.

02

Targets

IL21R (Interleukin-21 receptor)IL7R (Interleukin-7 Receptor)IL-15R (Interleukin 15 receptor alpha/interleukin 15 complex)IL-18R (Interleukin-18 receptor complex)IL-12R (Interleukin-12 receptor)

Beyond the preview

Go deeper on HCW9201 + HCW9206.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HCW9201 + HCW9206.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call